Similarly, it has been previously reported that upregulation of C-Mo and, in particular, higher numbers of CD14+ CD33+ HLA-DR cells and S100A8/9/12 expressing C-Mo are present in severe/critical COVID-19 and sepsis (30). This evidence concerns the gene CD33 and COVID-19.